Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Priyanka A. Pophali, Melissa C. Larson, Allison C. Rosenthal, Dennis Robinson, Thomas M. Habermann, Gita Thanarajasingam, Timothy Call, Cristine Allmer, Umar Farooq, Matthew J. Maurer, Kathleen J. Yost, James R. Cerhan & Carrie A. Thompson. (2021) The association of health behaviors with quality of life in lymphoma survivors. Leukemia & Lymphoma 62:2, pages 271-280.
Read now
Read now
Eliza M. Alawi, Krystyna A. Mathiak, Jens Panse & Klaus Mathiak. (2016) Health-related quality of life in patients with indolent and aggressive non-Hodgkin lymphoma. Cogent Psychology 3:1.
Read now
Read now
Anne W. Beaven, Greg Samsa, Sheryl Zimmerman & Sophia K. Smith. (2016) Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma. Cancer Investigation 34:6, pages 279-285.
Read now
Read now
Mette Seland, Harald Holte, Trine Bjøro, Thomas Schreiner, Jens Bollerslev, Jon Håvard Loge, Sophie D. Fosså & Cecilie E. Kiserud. (2015) Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region. Leukemia & Lymphoma 56:12, pages 3306-3314.
Read now
Read now
Articles from other publishers (6)
Afke Ekels, Lonneke V. van de Poll‐Franse, Eduardus F. M. Posthuma, Jacobien Kieffer, Djamila E. Issa, Adrianus Koster, Marten R. Nijziel, Johannes H. F. M. Pruijt, Wendy B. C. Stevens, Lidwine W. Tick & Simone Oerlemans. (2022)
Persistent symptoms of fatigue, neuropathy and role‐functioning impairment among indolent
non‐Hodgkin
lymphoma survivors: A longitudinal
PROFILES
registry study
. British Journal of Haematology 197:5, pages 590-601.
Crossref
Crossref
Grace Joshy, Joanne Thandrayen, Bogda Koczwara, Phyllis Butow, Rebekah Laidsaar-Powell, Nicole Rankin, Karen Canfell, John Stubbs, Paul Grogan, Louise Bailey, Amelia Yazidjoglou & Emily Banks. (2020) Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer. BMC Medicine 18:1.
Crossref
Crossref
Kah Poh Loh, Maya Abdallah, Anita J. Kumar, Nina R Neuendorff, Saurabh Dahiya & Heidi D. Klepin. (2019) Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper. Current Hematologic Malignancy Reports 14:6, pages 523-535.
Crossref
Crossref
Danbee Kang, Juhee Cho, Im Ryung Kim, Mi Kyung Kim, Won Seog Kim & Seok Jin Kim. (2018) Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study. Cancer Research and Treatment 50:4, pages 1051-1063.
Crossref
Crossref
Fredrik Salvesen Haukaas, Audun Ohna & Tania Krivasi. (2018) Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway. Applied Health Economics and Health Policy 16:4, pages 569-577.
Crossref
Crossref
Simone Oerlemans, Djamila E. Issa, Esther C. van den Broek, Marten R. Nijziel, Jan Willem W. Coebergh, Floortje Mols & Lonneke V. van de Poll-Franse. (2014) Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry. European Journal of Haematology 93:3, pages 229-238.
Crossref
Crossref